We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.77B
1-Year Est. Return 65.75%
This Fund
S&P 500
This Quarter Est. Return
+18.92%
1 Year Est. Return
+65.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.77B
AUM Growth
+$753M
Cap. Flow
+$549M
Cap. Flow %
19.8%
Top 10 Hldgs %
56.59%
Holding
245
New
66
Increased
5
Reduced
13
Closed
72

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$637M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$179M
4
O icon
Realty Income
O
+$77.9M
5
AAPL icon
Apple
AAPL
+$77.2M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$133M
2
FANG icon
Diamondback Energy
FANG
+$132M
3
SNDK
Sandisk
SNDK
+$79.4M
4
NRG icon
NRG Energy
NRG
+$65.8M
5
GFS icon
GlobalFoundries
GFS
+$57.2M

Sector Composition

Rank Sector Weight
1 Industrials 34.25%
2 Communication Services 15.05%
3 Technology 13.39%
4 Real Estate 12.74%
5 Healthcare 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
76
Dianthus Therapeutics
DNTH
$6.1B
$4.87M 0.18%
50,000
– –
MLTX icon
77
MoonLake Immunotherapeutics
MLTX
$1.27B
$4.87M 0.18%
+250,000
New +$4.53M
ORKA
78
Oruka Therapeutics
ORKA
$6.24B
$4.76M 0.17%
+50,000
New +$3.33M
TE
79
T1 Energy
TE
$1.49B
$4.74M 0.17%
500,000
– –
DFTX
80
Definium Therapeutics
DFTX
$5.14B
$4.7M 0.17%
100,000
– –
TNGX icon
81
Tango Therapeutics
TNGX
$3.83B
$4.69M 0.17%
+150,000
New +$3.71M
NTST
82
NETSTREIT Corp
NTST
$2.05B
$4.51M 0.16%
213,515
– –
MMED
83
MiniMed Group Inc
MMED
$6.56B
$4.49M 0.16%
300,000
– –
AMBQ
84
Ambiq Micro
AMBQ
$1.44B
$4.42M 0.16%
+50,000
New +$2.96M
PAYP
85
PayPay
PAYP
$11.9B
$4.3M 0.16%
300,000
– –
IMNM icon
86
Immunome
IMNM
$3.05B
$4.24M 0.15%
200,000
– –
MLYS icon
87
Mineralys Therapeutics
MLYS
$2.75B
$4.05M 0.15%
150,000
– –
APGE
88
DELISTED
Apogee Therapeutics
APGE
$3.98M 0.14%
30,000
– –
BOBS
89
Bobs Discount Furniture
BOBS
$2.29B
$3.96M 0.14%
250,000
– –
VOYG
90
Voyager Technologies
VOYG
$2.16B
$3.87M 0.14%
120,000
– –
CBC
91
Central Bancompany Inc
CBC
$7.79B
$3.8M 0.14%
125,000
– –
AVLN
92
Avalyn Pharma
AVLN
$1.67B
$3.79M 0.14%
+115,000
New +$3.32M
BETA
93
Beta Technologies Inc
BETA
$4.95B
$3.77M 0.14%
225,000
– –
CRNX
94
DELISTED
Crinetics Pharmaceuticals
CRNX
$3.74M 0.14%
100,000
– –
FDMT icon
95
4D Molecular Therapeutics
FDMT
$808M
$3.66M 0.13%
275,000
– –
IRON icon
96
Disc Medicine
IRON
$2.95B
$3.66M 0.13%
50,000
– –
LFTO
97
Liftoff Mobile
LFTO
$3.16B
$3.6M 0.13%
+150,000
New +$3.89M
AVBP icon
98
ArriVent BioPharma
AVBP
$1.49B
$3.47M 0.13%
100,000
– –
QURE icon
99
uniQure
QURE
$3.17B
$3.45M 0.12%
+75,000
New +$1.96M
TSHA icon
100
Taysha Gene Therapies
TSHA
$1.79B
$3.4M 0.12%
+500,000
New +$2.96M
2 3
4
5 6

Similar funds

C
Consulta London, United Kingdom $2.77B AUM 3.62% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.77B AUM 20.35% 1-Year Est. Return
JHP
James Hambro & Partners London, United Kingdom $2.76B AUM 19.67% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.76B AUM 18.08% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
CCM
Chickasaw Capital Management Memphis, Tennessee $2.78B AUM 20.87% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return

Burkehill Global Management's Q2 2026 Portfolio in Review

As of Q2 2026, Burkehill Global Management held 245 positions worth $2.77B, up 37% from $2.02B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Burkehill Global Management deployed $549M of net new capital in Q2 2026, opening 66 new positions and adding to 5 existing holdings. Its largest new stake was SpaceX: 3,750,000 shares worth $641M.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 19% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Galaxy Digital Inc, an estimated $33.4M trimmed.

  • Burkehill Global Management's largest Q2 2026 buy was SpaceX: 3,750,000 shares worth $641M.
  • Burkehill Global Management added most to SOLV Energy Inc in Q2 2026, an estimated $9.43M increase.
  • Burkehill Global Management's biggest Q2 2026 reduction was Galaxy Digital Inc, cutting an estimated $33.4M.
  • Burkehill Global Management fully exited Eli Lilly in Q2 2026, selling an estimated $133M.
  • Burkehill Global Management's ten largest holdings make up 57% of its $2.77B portfolio in Q2 2026.
  • Burkehill Global Management opened 66 new positions and closed 72 in Q2 2026.
  • Burkehill Global Management's portfolio value rose 37% quarter-over-quarter to $2.77B.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.